Heather Knight served as Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies of Baxter International, having been appointed COO effective February 3, 2025. On October 16, 2025, she notified the company of her decision to resign effective October 29, 2025, to join a company in the healthcare industry; following her departure Baxter no longer had a COO.
Ms. Knight led Baxter's Medical Products and Therapies segment beginning in 2023. From 2021 to 2023 she served as president of the company's Americas region and of its Acute Therapies, Clinical Nutrition, and Medication Delivery business units. She joined Baxter in 2019 as general manager, U.S. Hospital Products.
Throughout her 30-year career in the healthcare industry, Ms. Knight held numerous roles of increasing leadership in general management, global upstream and commercial capacities at companies including Medtronic plc, Covidien plc, Tyco International plc and Kendall Healthcare Products Company. Prior to joining Baxter, she most recently served as vice president and general manager in Medtronic's Surgical Innovations business. She earned her bachelor's degree in Biological Sciences from the University of Buffalo and completed the Executive Sales Strategy and Management program at the University of Chicago Booth School of Business. She serves as a director of Waters Corporation.